臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

	English \| 正體中文 \| 简体中文 \| 2809530
	???header.visitor??? : 27023283 ???header.onlineuser??? : 315 ???header.sponsordeclaration???

???search.scope???

???search.advance???

???search.login???

???search.administrator???

臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"黃玉瑜"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1???	???jsp.browse.items-by-author.order2???

Showing items 1-1 of 1 (1 Page(s) Totally)
1
View [10|25|50] records per page

Institution	Date	Title	Author
嘉南藥理大學	2020	Oral anticoagulants are widely used for long-term prevention of thromboembolism. Vitamin K antagonists, such as warfarin, were the most common oral anticoagulants in the past. Compared to warfarin, non-vitamin K antagonist oral anticoagulants (NOACs) have offered new options for outpatients, who need long term uses of anticoagulation. This is especially true when the first antidote of NOACs was launched in 2015. Cancer patients are at high risk of thrombosis, such as atrial fibrillation (AF) an	黃玉瑜

Showing items 1-1 of 1 (1 Page(s) Totally)
1
View [10|25|50] records per page